Yale University  

Calendar

A-Z Index

Yale-CURE BioHaven Entrepreneurship Seminar Series

The Yale-CURE BioHaven Entrepreneurship Series features presentations designed to showcase regionally developed life science technologies that have progressed along the path to commercialization. Speakers at the BioHaven events represent both the scientific and business side of the enterprises. The programs focus on key success factors of each company, scientific or technological advantage, business model, and lessons learned in starting and developing the business. The series also provides social networking opportunities for scientists/researchers in the Yale/New Haven community.

Click here for more information about CURE (Connecticut United for Research Excellence).

 

2011-2012 Events: Events Flyer

Registration for all BioHaven events is free for the Yale community and employees of CURE member companies. Please RSVP in advance. E-mail to biohaven@yale.edu or call the Yale Office of Cooperative Research at (203) 785-6209. Please see the flyer for all details.

 

Personalized

Medicine:

How Far Off?


CVG
When: Tuessday, February 28, 2012, 4:30 pm registration, 5:00 pm program, 6:00 pm networking, refreshments and wine bar
Where: Harkness Auditorium (NOTE LOCATION CHANGE)
Panelists: Richard Lifton, M.D., Ph.D., Sterling Professor of Genetics and Professor of Medicine (Nephrology), Yale University; Chair, Department of Genetics
Thomas Lynch, M.D., Director, Smilow Cancer Center at YNHH
Jonathan Rothberg, Ph.D. , Founder, CEO and Chairman, Ion Torrent Systems, Life Technologies
Timothy Shannon, M.D., Partner, Canaan Partners
Paul Pescatello (Moderator), President and CEO, CURE

Genomic technologies have opened the door to medicine that takes into account the unique clinical, genetic, genomic and environmental characteristics of individuals. This session will explore the state of personalized medicine today, its application both scientifically and in the clinic and commercial opportunities and challenges in the near and mid-term.

 

Soft Tissue

Regeneration, Inc.


STR
When: Thursday, March 29, 2012, 4:00 pm program, 5:00 pm networking, refreshments and wine bar
Where: The Anlyan Center
Speaker: Joseph Reilly, President and CEO

Soft Tissue Regeneration, Inc. (STR)
is an early-stage orthopaedic device company developing a breakthrough, tissue engineering platform used to regrow ligaments and tendons. STR’s first product, the L-C Ligament® is a ready to use, biocompatible and biodegradable synthetic scaffold that facilitates re-growth of a patient’s anterior cruciate ligament (ACL) within the knee – providing joint stabilization and ultimately resulting in faster, better healing and greater odds of making a full recovery. The Company’s proprietary and patented technology utilizes and FDA-approved degradable polymer.

 

Chondrogenics,

Inc.

When: Thursday, April 26, 2012, 4:00 pm program, 5:00 pm networking, refreshments and wine bar
Where: The Anlyan Center
Speakers: Caroline Dealy, Ph.D., Scientific Founder and Associate Professor, Center for Regenerative Medicine and Skeletal Development, UConn Health Center
James Heym, Ph.D., Senior Director of Life Science Ventures, UConn R&D Corp.

Chondrogenics, Inc. is developing stem cell therapy for the treatment of osteoarthritis and the repair of damaged cartilage associated with diseased and damaged joints. Dr. Dealy and colleagues have developed a novel process for producing substantially homogeneous populations of chondrogenic cells and earlier progenitor cells from stem cells, including induced pluripotent stem cells.

 

Past Seminars:

 

Thetis

Pharmaceuticals,

Inc.

When: Wednesday, January 25, 2012, 4:00 pm program, 5:00 pm networking, refreshments and wine bar
Where: The Anlyan Center
Speakers: Gary Mathias, Chief Financial Officer
Frank Sciavolino, Ph.D., Chief Scientific Officer and Co-founder
Thetis Pharmaceuticals is a drug development company that is advancing TP101, a novel, first-line therapy for type 2 diabetes. TP101 is a new molecular entity that chemically combines metformin, the standard of care in type 2 diabetes, with the principal component from omega-3 polyunsaturated fatty acids. TP101 uniquely targets both glycemic and lipid control in diabetes patients and, for the first time, offers prospects for addressing the high incidence of cardiovascular complications, a major risk factor in type 2 diabetic and pre-diabetic patients. The company expects to begin clinical studies with TP101 in 2012.

 

Healthcare IT:

Challenges and

Opportunities


CVG
When: Tuesday, November 15, 2011, 4:30 pm registration, 5:00 pm program, 6:00 pm networking, refreshments and wine bar
Where: The Anlyan Center
Panelists: David Jahnes, Managing Partner, Galen Partners
James Staten, Executive VP, Corporate and Financial Services, YNHHS and CFO and Senior VP for Finance, Yale-New Haven Hospital
Matt Walton, CEO, MyCare LLC

Health IT is a booming field. Document management for Electronic Health Records and demands for mobility while ensuring the security of medical records are major concerns for providers. Entrepreneurs are navigating a regulatory environment that is more complex than ever before while racing to implement the connectivity required for Healthcare Information Exchanges. How are providers incorporating clinical decision support into practices? Where are investors putting their money? An all-star panel of a hospitalist, a regulatory expert, an investor and entrepreneur talk about where Health IT is trending.

 

Axerion

 

Therapeutics

When: Wednesday, March 2, 2011, 4:00pm seminar, 5:00pm networking, refreshments and wine bar
Where: The Anlyan Center
Speaker: Sylvia McBrinn President and Chief Executive Officer;
Stephen Strittmatter, M.D. Ph.D.;
Vincent Coates Professor of Neurology, Yale University
Professor of Neurobiology, Yale University
  Archive: Video

 

novatract

When: Wednesday, February 16, 2011, 4:00pm seminar, 5:00pm networking, refreshments and wine bar
Where: The Anlyan Center
Speaker: Eleanor Trandler President and CEO; Kurt Roberts, M.D. Assistant Professor of Surgery, Yale University
  Archive: Video

 

miradx

When: Wednesday, January 19, 2011, 4:00pm seminar, 5:00pm networking, refreshments and wine bar
Where: The Anlyan Center
Speaker: Martin L. Verhoef, President ; Frank Slack, Ph.D. Associate Professor, Department of Molecular, Cellular and Developmental Biology, Yale University
  Archive: Video

 

biodel

When: Thursday, November 18, 2010, 4:00pm seminar, 5:00pm networking, refreshments and wine bar
Where: Yale Epidemiology & Public Health Building (LEPH), 1st Floor, Winslow Auditorium, 60 College Street (corner of South Frontage Road), New Haven (NOTE LOCATION CHANGE)
Speaker: Solomon S. Steiner, Ph.D. Chief Scientific Officer and Co-Founder; Erroll De Souza, Ph.D. President and CEO
  Archive: Video

 

cobalt

When: Wednesday, October 27, 2010, 4:00pm seminar, 5:00pm networking, refreshments and wine bar
Where: Hope Auditorium
Speaker: Seth Feuerstein, M.D., J.D. Cobalt Therapeutics
  Archive: Video

 

Al Mann

When: Thursday, September 16, 2010, 6:00pm seminar, 7:00pm networking, refreshments and wine bar
Where: Hope auditorium, Yale Medical School (300 Cedar Street)
Speaker:

 

Alfred E. Mann has founded and largely funded 17 companies in his career. Nine were acquired at an overall total of almost $8 billion, and two became public companies. He is currently chairman and EO of Mannkind Corporation.
  Archive: Video

 

 

 

 

 

 

 

 

kolltan

When: Wednesday, May 26, 2010
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speaker: Arthur G. Altschul, Jr., Co-Founder and Chairman of the Board; Joseph Schlessinger, Ph.D., Co-Founder, Director and Scientific Advisory Board Chairman and Michael Schmertzler, Chief Executive Officer
  Archive: Video

 

js genetics

When: Wednesday, May 12, 2010
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speaker: Alidad Mireskandari, President & CEO and Jeff Gruen, M.D., Co-founder of JS Genetics, Scientific Advisory Board Chairman
  Archive: Video

 

Amarin

When: Thursday, April 8, 2010
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speaker: Paresh Soni, M.D., PhD, Senior Vice President and Head of Development
  Archive: Video

 

Jonathan Rothberg When: Wednesday, March 31, 2010
Where: 110 Hope Memorial Building, 315 Cedar Street
Speaker: Jonathan Rothberg, Founder of 454 Life Sciences, CuraGen, Clarifi Corporation, The Rothberg Institute of Childhood Diseases, Ion Torrent Systems, Founder and chair, RainDance Technologies

 

Arbor Fuel When: Thursday, February 25, 2010
Where: Yale University, Kline Geology Lab Building, 210 Whitney Ave, New Haven
Speaker: Steven Henck, President & CEO

 

 

Advanced Orthopedic Technologies & CardioPhotonics When: Thursday, January 28, 2010
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speaker: Thomas Wood, President & CEO; John S. Reach, M.Sc., M.D.; Kirk Shelley, M.D., Ph.D.
  Archive: Video

 

helix When: Wednesday, November 18, 2009
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speaker: Joseph Catino, Ph.D.; Peter M. Glazer, M.D., Ph.D.

 

CaraTherapeutics When: Wednesday, October 21, 2009
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speaker: Derek Chalmers, Ph.D., D.Sc, President & CEO

 

 

When: Wednesday, May 6, 2009
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speakers: Michael Sherman, President, and Michael Weiner, Vice President of Molecular Sciences
  Archive: Broadband | Modem
(RealPlayer required)

 

Cell Design When: Wednesday, March 25, 2009
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speakers: John Hambor, Ph.D., Chief Executive Officer, CellDesign and Linda Powers, Co-Founder and Managing Director, Toucan Capital, Inc.
  Archive: Powerpoint
  Archive: Broadband (RealPlayer required)

 

carigentlogo

 

When: Thursday, March 5, 2009
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speakers: Seth Feuerstein MD JD, President; W. Mark Saltzman PhD. Scientific Advisor and Tarek Fahmy PhD. Scientific Advisor
  Archive: Broadband (RealPlayer required)

 

Unexpected Outcomes: Navigating Scientific & Management Land Mines

 

When: Thursday, November 13, 2008
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speakers: Michael Kishbauch, Ph.D., President & CEO, Achillion Pharmaceuticals Inc.; Tom Wood, Founding CEO, Applied Spine Technologies; Ron Lennox, D. Phil., Partner, CHL Medical Parnters
    More info...

 

When: Thursday, October 16, 2008
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speakers: Geoffrey Erickson, Ph.D., President & CEO, Humacyte, Inc.
Laura Niklason, M.D., Ph.D., Founder & CSO, Humacyte, Inc., Associate Professor of Anesthesia & Biomedical Engineering, Yale University
    More info...

 

When: March 19, 2008
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speakers: Colin Foster, President and Chief Executive Office, Optherion
Amanda Hayward, Ph.D., Senior Vice President, Scheer & Company, Inc.
    More info...

When: April 16, 2008
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speakers: Roger Longman, Managing Partner, Windhover Information Inc.(moderator)
William Burkoth, Senior Manager, Pfizer’s Venture Investments Group, Pfi zer Inc.
Richard Flavell, Ph.D., Professor and Chairman of Immunobiology; Professor of Molecular, Cellular & Developmental Biology, Yale University; Investigator, Howard Hughes Medical Institute
Haifan Lin, Ph.D., Professor of Cell Biology; Director, Yale Stem Cell Center
David Scheer, President, Scheer & Company, Inc.
    More info...

When: April 23, 2008
Where: The Anlyan Center auditorium, Yale Medical School (300 Cedar Street)
Speakers: Ben Bronstein, M.D., Co-founder; President/ COO, Vidas Ocular
Bruce Shields, M.D., Marvin L. Sears Professor and Chairman Emeritus, Department of Opthamology and Visual Science, Yale University School of Medicine; Co-Founder; Chief Scientific
and Medical Officer, Vidus Ocular
    More info...

 

When: February 12, 2008
Speakers: Susan Froshauer, Ph.D.
President and CEO, Rib-X
Archive: Broadband | Modem
(RealPlayer required)
    More info...

More information... (pdf)
When: November 13, 2007
Speakers: John P. Marano, Jr., Ph.D., Co-Founder, President & CEO, Vascular Insights LLC
Michael Tal, M.D., Associate Professor of Radiology, Yale School of Medicine; Co-Founder, and Chief Medical Advisor, Vascular Insights LLC
Archive: PowerPoint
Video:
Broadband | Modem
(RealPlayer required)
  More info...

When: October 24, 2007
Speakers: Ronald W. Lennox, D. Phil. Partner, CHL Medical Partners and Interim CEO, BioRelix Pharmaceuticals, Inc.
Ronald Breaker, Ph.D. Henry Ford II Professor in the Department of Molecular, Cellular and Developmental Biology, Yale University; Investigator, Howard Hughes Medical Institute
Video:
Broadband | Modem
(RealPlayer required)
    More info...

When: January 17, 2007
Speakers: Peter Fuller, Ph.D., Chief Operating Officer, CGI Pharmaceuticals, Inc.
Ira Mellman, Ph.D., Yale University Sterling Professor of Cell Biology & Immunology; Founder & Scientific Advisor, CGI Pharmaceuticals, Inc.
Video:
Broadband | Modem
(RealPlayer required)

 

 

 





 

Applied Spine Technologies
Applied Spine Technologies
When: December 13, 2005
Speakers: Tom Wood, Applied Spine
Manohar Panjabi, Yale
Video:
(MPEG®)
(RealPlayer required)

 
Top of page.